Washburn Capital Management, Inc. Abbott Laboratories Transaction History

Washburn Capital Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$95.06 - $111.52 $176,621 - $207,204	1,858 New	1,858 $204,000
Q2 2022 Jul 15, 2022	SELL	$102.07 - $123.37 $28,987 - $35,037	-284 Reduced 11.06%	2,283 $248,000
Q1 2022 May 06, 2022	BUY	$114.02 - $139.04 $18,813 - $22,941	165 Added 6.87%	2,567 $304,000
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $17,382 - $19,229	-149 Reduced 5.84%	2,402 $283,000
Q2 2021 Aug 02, 2021	SELL	$105.79 - $124.53 $18,513 - $21,792	-175 Reduced 6.42%	2,551 $296,000
Q1 2021 May 03, 2021	SELL	$108.84 - $128.23 $16,326 - $19,234	-150 Reduced 5.22%	2,726 $327,000
Q4 2020 Jan 28, 2021	BUY	$105.0 - $114.42 $21,105 - $22,998	201 Added 7.51%	2,876 $315,000
Q3 2020 Oct 07, 2020	BUY	$91.64 - $111.29 $245,137 - $297,700	2,675 New	2,675 $291,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Washburn Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Washburn Capital Management, Inc. with notifications on news.